{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T01:39:55Z","timestamp":1793756395300,"version":"4.6.1"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,20]],"date-time":"2025-06-20T00:00:00Z","timestamp":1750377600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,6,20]],"date-time":"2025-06-20T00:00:00Z","timestamp":1750377600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Outstanding Leaders Training Program of Pudong New Area Health System of Shanghai","award":["PWRl 2020\u201008"],"award-info":[{"award-number":["PWRl 2020\u201008"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Med Res"],"DOI":"10.1186\/s40001-025-02700-6","type":"journal-article","created":{"date-parts":[[2025,6,20]],"date-time":"2025-06-20T05:15:40Z","timestamp":1750396540000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Investigating the efficacy of calcipotriol\u2013acitretin combination therapy versus monotherapy protocols in psoriasis and its effect on serum inflammatory factors: a systematic review and meta-analysis"],"prefix":"10.1186","volume":"30","author":[{"given":"Huiyun","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiantian","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuesong","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhua","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,20]]},"reference":[{"key":"2700_CR1","doi-asserted-by":"publisher","first-page":"113551","DOI":"10.1016\/j.jep.2020.113551","volume":"268","author":"Y Li","year":"2021","unstructured":"Li Y, et al. Clinical trait-connected network analysis reveals transcriptional markers of active psoriasis treatment with Liangxue-Jiedu decoction. J Ethnopharmacol. 2021;268:113551.","journal-title":"J Ethnopharmacol"},{"key":"2700_CR2","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.molimm.2021.01.019","volume":"132","author":"X Tian","year":"2021","unstructured":"Tian X, et al. Pentacyclic triterpene compounds from loquat leaves reduce skin inflammation and epidermal hyperplasia in psoriasis via inhibiting the Th17 cells. Mol Immunol. 2021;132:30\u201340.","journal-title":"Mol Immunol"},{"issue":"2","key":"2700_CR3","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1358\/dnp.2008.21.2.1188196","volume":"21","author":"R Heidenreich","year":"2008","unstructured":"Heidenreich R, R\u00f6cken M, Ghoreschi K. Angiogenesis: the new potential target for the therapy of psoriasis? Drug News Perspect. 2008;21(2):97\u2013105.","journal-title":"Drug News Perspect"},{"issue":"98","key":"2700_CR4","first-page":"97","volume":"18","author":"W Li","year":"2014","unstructured":"Li W, et al. Targeting VEGF\/VEGFR in the treatment of psoriasis. Discov Med. 2014;18(98):97\u2013104.","journal-title":"Discov Med"},{"issue":"7","key":"2700_CR5","doi-asserted-by":"publisher","first-page":"4015","DOI":"10.1128\/MCB.17.7.4015","volume":"17","author":"S Yoshida","year":"1997","unstructured":"Yoshida S, et al. Involvement of interleukin-8, vascular endothelial growth factor, and basic fibroblast growth factor in tumor necrosis factor alpha-dependent angiogenesis. Mol Cell Biol. 1997;17(7):4015\u201323.","journal-title":"Mol Cell Biol"},{"issue":"3","key":"2700_CR6","first-page":"177","volume":"47","author":"D Aleem","year":"2018","unstructured":"Aleem D, Tohid H. Pro-inflammatory cytokines, biomarkers, genetics and the immune system: a mechanistic approach of depression and psoriasis. Rev Colomb Psiquiatr (Engl Ed). 2018;47(3):177\u201386.","journal-title":"Rev Colomb Psiquiatr (Engl Ed)"},{"issue":"20","key":"2700_CR7","doi-asserted-by":"publisher","first-page":"7488","DOI":"10.3390\/ijms21207488","volume":"21","author":"M Tokuyama","year":"2020","unstructured":"Tokuyama M, Mabuchi T. New treatment addressing the pathogenesis of psoriasis. Int J Mol Sci. 2020;21(20):7488.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"2700_CR8","first-page":"278","volume":"63","author":"WB Kim","year":"2017","unstructured":"Kim WB, Jerome D, Yeung J. Diagnosis and management of psoriasis. Can Fam Phys. 2017;63(4):278\u201385.","journal-title":"Can Fam Phys"},{"issue":"3","key":"2700_CR9","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.jdermsci.2015.12.009","volume":"81","author":"P Lovatoa","year":"2016","unstructured":"Lovatoa P, et al. Calcipotriol and betamethasone dipropionate exert additive inhibitory effects on the cytokine expression of inflammatory dendritic cell-Th17 cell axis in psoriasis. J Dermatol Sci. 2016;81(3):153\u201364.","journal-title":"J Dermatol Sci"},{"issue":"3","key":"2700_CR10","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1007\/s13555-017-0196-z","volume":"7","author":"S Segaert","year":"2017","unstructured":"Segaert S, et al. Optimizing anti-inflammatory and immunomodulatory effects of corticosteroid and vitamin D analogue fixed-dose combination therapy. Dermatol Ther (Heidelb). 2017;7(3):265\u201379.","journal-title":"Dermatol Ther (Heidelb)"},{"issue":"7240","key":"2700_CR11","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1136\/bmj.320.7240.963","volume":"320","author":"DM Ashcroft","year":"2000","unstructured":"Ashcroft DM, et al. Systematic review of comparative efficacy and tolerability of calcipotriol in treating chronic plaque psoriasis. BMJ. 2000;320(7240):963\u20137.","journal-title":"BMJ"},{"issue":"5","key":"2700_CR12","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1111\/ijd.12365","volume":"53","author":"MD Sunil Dogra","year":"2014","unstructured":"Sunil Dogra MD, Savita Yadav M. Acitretin in psoriasis: an evolving scenario. Int J Dermatol. 2014;53(5):525\u201338.","journal-title":"Int J Dermatol"},{"issue":"7","key":"2700_CR13","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1016\/j.ad.2013.01.003","volume":"104","author":"G Carretero","year":"2013","unstructured":"Carretero G, et al. Guidelines for the use of acitretin in psoriasis. Psoriasis Group of the Spanish Academy of Dermatology and Venereology. Actas Dermosifiliogr. 2013;104(7):598\u2013616.","journal-title":"Actas Dermosifiliogr"},{"key":"2700_CR14","doi-asserted-by":"publisher","first-page":"106045","DOI":"10.1016\/j.intimp.2019.106045","volume":"79","author":"J Tu","year":"2020","unstructured":"Tu J, et al. Acitretin inhibits IL-17A-induced IL-36 expression in keratinocytes by down-regulating IkappaBzeta. Int Immunopharmacol. 2020;79:106045.","journal-title":"Int Immunopharmacol"},{"key":"2700_CR15","doi-asserted-by":"publisher","first-page":"S18","DOI":"10.1016\/S0190-9622(99)70361-0","volume":"41","author":"HH Roenigk","year":"1999","unstructured":"Roenigk HH. Acitretin combination therapy. J Am Acad Dermatol. 1999;41:S18-21.","journal-title":"J Am Acad Dermatol"},{"issue":"7","key":"2700_CR16","doi-asserted-by":"publisher","first-page":"e1000100","DOI":"10.1371\/journal.pmed.1000100","volume":"6","author":"A Liberati","year":"2009","unstructured":"Liberati A, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med. 2009;6(7):e1000100.","journal-title":"PLoS Med"},{"issue":"7","key":"2700_CR17","doi-asserted-by":"publisher","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","volume":"6","author":"D Moher","year":"2009","unstructured":"Moher D, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7):e1000097.","journal-title":"PLoS Med"},{"issue":"15","key":"2700_CR18","first-page":"2819","volume":"27","author":"Y Meng","year":"2018","unstructured":"Meng Y. Clinical effect of acitretin capsule combined with calcipotriol ointment in the treatment of psoriasis. Henan Med Res. 2018;27(15):2819\u201320.","journal-title":"Henan Med Res"},{"issue":"3","key":"2700_CR19","first-page":"433","volume":"33","author":"D Wang","year":"2020","unstructured":"Wang D. The clinical efficacy and adverse reactions of acitretin combined with calcipotriol in the treatment of psoriasis vulgaris. J Med Theor Prac. 2020;33(3):433\u20134.","journal-title":"J Med Theor Prac"},{"issue":"5","key":"2700_CR20","first-page":"421","volume":"17","author":"Y Wei","year":"2018","unstructured":"Wei Y, Xiong L, Wan J. The efficacy of acitretin combined with calcipotriol in the treatment of psoriasis vulgaris and its effect on serum inflammatory factors. Chin J Dermato Venerol Integ Trad W Med. 2018;17(5):421\u20133.","journal-title":"Chin J Dermato Venerol Integ Trad W Med"},{"issue":"1","key":"2700_CR21","first-page":"65","volume":"41","author":"G Hou","year":"2019","unstructured":"Hou G. Efficacy of acitretin capsule combined with calcipotriol ointment in the treatment of psoriasis. J Dermatol Venereol. 2019;41(1):65\u20137.","journal-title":"J Dermatol Venereol"},{"issue":"3","key":"2700_CR22","first-page":"381","volume":"30","author":"X Yu","year":"2019","unstructured":"Yu X. The efficacy of acitretin combined with calcipotriol in the treatment of psoriasis vulgaris and its effect on serum inflammatory factors. Mod Diagn Treat. 2019;30(3):381\u20133.","journal-title":"Mod Diagn Treat"},{"issue":"1","key":"2700_CR23","first-page":"60","volume":"42","author":"J Li","year":"2020","unstructured":"Li J. Effect of calcipotriol ointment combined with acitretin in the treatment of psoriasis. J Dermatol Venereol. 2020;42(1):60\u20132.","journal-title":"J Dermatol Venereol"},{"issue":"1","key":"2700_CR24","first-page":"38","volume":"19","author":"L Shen","year":"2020","unstructured":"Shen L, Nie L. Effects of calcipotriol combined with acitretin on psoriasis area and severity index and level of vascular endothelial growth factor in psoriasis patients. Chin J Dermato Venerol Integ Trad W Med. 2020;19(1):38\u201340.","journal-title":"Chin J Dermato Venerol Integ Trad W Med"},{"issue":"21","key":"2700_CR25","first-page":"128","volume":"5","author":"A Zuo","year":"2020","unstructured":"Zuo A. The clinical effect and adverse reaction of avia combined with carbotriol in the treatment of psoriasis vulgaris. Syst Med. 2020;5(21):128\u201330.","journal-title":"Syst Med"},{"issue":"31","key":"2700_CR26","first-page":"49","volume":"28","author":"X Chen","year":"2021","unstructured":"Chen X, et al. Clinical effect of Calcipotriol combined with Acitretin Capsules in the treatment of common psoriasis vulgaris. China Mod Med. 2021;28(31):49\u201352.","journal-title":"China Mod Med"},{"issue":"12","key":"2700_CR27","first-page":"74","volume":"28","author":"L Junming","year":"2021","unstructured":"Junming L, Miaohua T, Guizhen C. Clinical effect of Acitretin combined with Capestriol Ointment in the treatment of plaque psoriasis. China Mod Med. 2021;28(12):74\u20136.","journal-title":"China Mod Med"},{"issue":"24","key":"2700_CR28","first-page":"127","volume":"14","author":"J Zheng","year":"2021","unstructured":"Zheng J. The clinical efficacy of acitretin combined with calcipotriol ointment in the treatment of plaque psoriasis. Chin J Clin Ration Drug Use. 2021;14(24):127\u20139.","journal-title":"Chin J Clin Ration Drug Use"},{"issue":"06","key":"2700_CR29","first-page":"616","volume":"41","author":"L Huanhuan","year":"2024","unstructured":"Huanhuan L. Clinical observation of acitretin capsule combined with calcipotriol ointment in the treatment of psoriasis. Chin Med J Metall Ind. 2024;41(06):616.","journal-title":"Chin Med J Metall Ind"},{"issue":"06","key":"2700_CR30","first-page":"41","volume":"40","author":"W Xia","year":"2024","unstructured":"Xia W, Lingling L. Effect analysis of Calcipotriol combined with Acitretin capsule in treatment of psoriasis vulgaris. Chin Community Drs. 2024;40(06):41\u20133.","journal-title":"Chin Community Drs"},{"issue":"3","key":"2700_CR31","first-page":"247","volume":"88","author":"ME Marina","year":"2015","unstructured":"Marina ME, et al. VEGF involvement in psoriasis. Clujul Med. 2015;88(3):247\u201352.","journal-title":"Clujul Med"},{"issue":"1","key":"2700_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1046\/j.1523-1747.1998.00262.x","volume":"111","author":"M Detmar","year":"1998","unstructured":"Detmar M, et al. Increased microvascular density and enhanced leukocyte rolling and adhesion in the skin of VEGF transgenic mice. J Invest Dermatol. 1998;111(1):1\u20136.","journal-title":"J Invest Dermatol"},{"issue":"1","key":"2700_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jdermsci.2011.04.007","volume":"63","author":"AW Armstrong","year":"2011","unstructured":"Armstrong AW, et al. Angiogenesis and oxidative stress: common mechanisms linking psoriasis with atherosclerosis. J Dermatol Sci. 2011;63(1):1\u20139.","journal-title":"J Dermatol Sci"},{"issue":"1","key":"2700_CR34","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1074\/jbc.275.1.642","volume":"275","author":"BV Diaz","year":"2000","unstructured":"Diaz BV, et al. Regulation of vascular endothelial growth factor expression in human keratinocytes by retinoids. J Biol Chem. 2000;275(1):642\u201350.","journal-title":"J Biol Chem"},{"issue":"4","key":"2700_CR35","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1023\/A:1024515517623","volume":"5","author":"D Creamer","year":"2002","unstructured":"Creamer D, et al. Angiogenesis in psoriasis. Angiogenesis. 2002;5(4):231\u20136.","journal-title":"Angiogenesis"},{"issue":"8","key":"2700_CR36","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1139\/cjpp-2015-0483","volume":"94","author":"T Chen","year":"2016","unstructured":"Chen T, et al. Paeoniflorin suppresses inflammatory response in imiquimod-induced psoriasis-like mice and peripheral blood mononuclear cells (PBMCs) from psoriasis patients. Can J Physiol Pharmacol. 2016;94(8):888\u201394.","journal-title":"Can J Physiol Pharmacol"},{"key":"2700_CR37","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.cellimm.2018.04.016","volume":"331","author":"F Zhou","year":"2018","unstructured":"Zhou F, et al. NFKB1 mediates Th1\/Th17 activation in the pathogenesis of psoriasis. Cell Immunol. 2018;331:16\u201321.","journal-title":"Cell Immunol"},{"issue":"2","key":"2700_CR38","doi-asserted-by":"publisher","first-page":"e123390","DOI":"10.1172\/jci.insight.123390","volume":"4","author":"B Germ\u00e1n","year":"2019","unstructured":"Germ\u00e1n B, et al. Disrupting the IL-36 and IL-23\/IL-17 loop underlies the efficacy of calcipotriol and corticosteroid therapy for psoriasis. JCI Insight. 2019;4(2):e123390.","journal-title":"JCI Insight"},{"key":"2700_CR39","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1111\/j.0105-2896.2006.00400.x","volume":"211","author":"KE Foulds","year":"2006","unstructured":"Foulds KE, Wu C, Seder RA. Th1 memory: implications for vaccine development. Immunol Rev. 2006;211:58\u201366.","journal-title":"Immunol Rev"},{"key":"2700_CR40","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1146\/annurev.immunol.23.021704.115821","volume":"24","author":"KM Ansel","year":"2006","unstructured":"Ansel KM, et al. Regulation of Th2 differentiation and Il4 locus accessibility. Annu Rev Immunol. 2006;24:607\u201356.","journal-title":"Annu Rev Immunol"},{"issue":"1","key":"2700_CR41","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1089\/acm.2019.0409","volume":"27","author":"L Liu","year":"2021","unstructured":"Liu L, et al. Fire needle therapy for the treatment of psoriasis: a quantitative evidence synthesis. J Altern Complement Med. 2021;27(1):24\u201337.","journal-title":"J Altern Complement Med"},{"issue":"3","key":"2700_CR42","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s12016-016-8535-x","volume":"50","author":"Y Deng","year":"2016","unstructured":"Deng Y, Chang C, Lu Q. The inflammatory response in psoriasis: a comprehensive review. Clin Rev Allergy Immunol. 2016;50(3):377\u201389.","journal-title":"Clin Rev Allergy Immunol"},{"issue":"1","key":"2700_CR43","doi-asserted-by":"publisher","first-page":"134","DOI":"10.3390\/molecules22010134","volume":"22","author":"P Fasching","year":"2017","unstructured":"Fasching P, et al. Therapeutic Potential of Targeting the Th17\/Treg Axis in Autoimmune Disorders. Molecules. 2017;22(1):134.","journal-title":"Molecules"}],"container-title":["European Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-02700-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40001-025-02700-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-02700-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,20]],"date-time":"2025-06-20T17:02:43Z","timestamp":1750438963000},"score":1,"resource":{"primary":{"URL":"https:\/\/eurjmedres.biomedcentral.com\/articles\/10.1186\/s40001-025-02700-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,20]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2700"],"URL":"https:\/\/doi.org\/10.1186\/s40001-025-02700-6","relation":{},"ISSN":["2047-783X"],"issn-type":[{"value":"2047-783X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,20]]},"assertion":[{"value":"28 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"501"}}